The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Coronary interventions

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study

EuroIntervention 2015;11:555-563 published online ahead of print December 2014. DOI: 10.4244/EIJY14M12_07

1. Cardiology Department, Hospital Sant Pau, Barcelona, Spain; 2. Interventional Cardiology Unit, Hospital del Mar, Barcelona, Spain; 3. Perceptual Computing Lab, Faculty of Mathematics, University of Barcelona, Barcelona, Spain

Aims: We sought to assess the safety and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) in percutaneous chronic total occlusion (CTO) revascularisation

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)